Use of high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and / or preventing diseases caused by calcium suppression

• 收藏
• 分享

专利权人:

サントル、ナショナール、ド、ラ、ルシェルシュ、シアンティフィク、（セーエヌエルエス）;サントル、ナショナール、ド、ラ、ルシェルシュ、シアンティフィク、(セーエヌエルエス)

发明人:

フラン、ザル,モルガヌ、ルースロ

申请号：

JP2008551775

公开号：

JP5318585B2

申请日:

2007.01.23

申请国别(地区):

JP

年份:

2013

代理人:

摘要：

The present invention relates to the use of a high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and/or preventing diseases by inhibition of calcium. Advantageously, the extracellular hemoglobin is obtained from Annelids. In particular, the invention concerns the use of a high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and/or preventing cardiovascular diseases, such as hypertension, angina such as angina pectoris, Raynaud's disease, arteriopathy, tachycardia, vasospasm, ischemia, myocardial infarction, congestive heart failure, arrhythmia or cerebrovacular accident.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/